← Back to search
VENATORX PHARMACEUTICALS INC
CHADDS FORD, PA, 19317
UnclaimedClaim this profile (free)
Prime contracting experience
5 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF - ORALLY BIOAVAILABLEβ-LACTAM/β-LACTAMASE INHIBITOR COMBINATION FOR BIODEFENSE AND PUBLIC HEALTH. | — | $48,517,079 | Jul 31, 2026 | Sep 19, 2016 – Mar 31, 2026 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | VENATORX PHARMACEUTICALS, INC. | — | $106,573,640 | May 26, 2026 | Jul 17, 2019 – Sep 30, 2025 |
| Prime | Department of Health and Human Services Office of Assistant Secretary for Preparedness and Response | VENATORX PHARMACEUTICALS: ANTIBIOTIC FOR AMR AND BIOTHREAT PATHOGENS | — | $72,141,707 | May 13, 2026 | Sep 27, 2022 – Dec 31, 2028 |
| Prime | Department of Defense Defense Threat Reduction Agency | PENICILLIN BINDING PROTEINS IGF::OT::IGF | — | $14,256,515 | Apr 30, 2026 | Aug 28, 2017 – Apr 30, 2022 |
| Prime | Department of Health and Human Services National Institutes of Health | IGF::OT::IGF DEVELOPMENT OF THERAPEUTIC MEDICAL COUNTERMEASURES FOR BIODEFENSE AND EMERGING INFECTIOUS DISEASES | — | $28,199,896 | Jun 30, 2023 | Sep 16, 2013 – Sep 30, 2019 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
- Department of DefenseGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.